Beyond Point Solutions: Multi-Condition Support for Total Cost of Care
Health plans are being asked to solve for total cost of care across a growing set of overlapping conditions — obesity, diabetes, hypertension, cholesterol, and multi-condition members at the intersection of all of them. GLP-1 utilization has intensified the pressure, surfacing sustainability questions that no single-condition vendor is positioned to answer on its own. This webinar reframes the payer conversation from vendor evaluation to partner strategy, focusing on how a multi-condition cardiometabolic care platform can plug into a plan’s own total-cost-of-care approach across multiple lines of business.
This conversation will explore what “partner, not vendor” looks like in practice for fully-insured, ASO, Medicare, Medicaid, and federal employee cohorts, and how plans can evaluate multi-condition care solutions on the terms that actually matter: cost defensibility, clinical efficacy their teams can stand behind, and a partnership model built on care across conditions, rather than single-condition vendors.
In this session, the speakers will cover
- Why the payer conversation has shifted from “add another vendor” to “better, deeper partnerships”
- Omada’s recently-published report highlighting the value of virtual cardiometabolic support
- What those findings may mean for a plan’s total-cost-of-care strategy
Speakers
Thomas Tsang, MD, MPH
Dr. Thomas Tsang is a clinician and healthcare executive with wide-ranging professional experience. Dr. Tsang was previously the founding CEO of Valera Health, a venture-backed tele-mental healthcare company. While there, he helped Valera grow from six to over 500 employees and earn recognition by Fast Company for innovation and impact. He also worked on the Affordable Care Act while serving in the U.S. House Ways and Means Committee, and helped the Department of Health and Human Services (HHS) shape a national framework for electronic health records. He’s currently on the board of the National Committee for Quality Assurance (NCQA).
Sachin Jain, MD, MBA
Dr. Jain leads SCAN, an $8B nonprofit serving nearly 500,000 members across six states. He previously led CareMore and Aspire Health, served as Chief Medical Information & Innovation Officer at Merck and as a senior CMS advisor and CMMI deputy director. A Harvard graduate, he teaches at Stanford, sits on the Omada Health board, and is author of the forthcoming book The Moral Alibi.
Melissa Cellucci
Melissa Cellucci is National Vice President of Health Plan Growth at Omada Health, a growth executive passionate about transforming healthcare through innovative partnerships, market-driven strategy, and solutions that improve outcomes, affordability, and the member experience. She has driven enterprise growth for health plans and payers across Commercial, Medicare, Medicaid, ACA, Blue, and National plans, with prior leadership roles at Included Health, Doctor On Demand, and VirtualHealth.